David M. Scollard

4.0k total citations · 1 hit paper
80 papers, 2.4k citations indexed

About

David M. Scollard is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, David M. Scollard has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 44 papers in Epidemiology and 41 papers in Surgery. Recurrent topics in David M. Scollard's work include Leprosy Research and Treatment (69 papers), Mycobacterium research and diagnosis (42 papers) and Infectious Diseases and Tuberculosis (39 papers). David M. Scollard is often cited by papers focused on Leprosy Research and Treatment (69 papers), Mycobacterium research and diagnosis (42 papers) and Infectious Diseases and Tuberculosis (39 papers). David M. Scollard collaborates with scholars based in United States, Brazil and Thailand. David M. Scollard's co-authors include Richard W. Truman, Diana L. Williams, Linda B. Adams, James L. Krahenbuhl, Tom Gillis, Thomas P. Gillis, Gigi J. Ebenezer, Rahul Sharma, Pushpendra Singh and M. Patricia Joyce and has published in prestigious journals such as New England Journal of Medicine, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

David M. Scollard

75 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Continuing Challenges of Leprosy

2006 601 citations David M. Scollard, Linda B. Adams et al. profile →

Peers

Countries citing papers authored by David M. Scollard

Since Specialization

Citations

This map shows the geographic impact of David M. Scollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Scollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Scollard more than expected).

Fields of papers citing papers by David M. Scollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Scollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Scollard. The network helps show where David M. Scollard may publish in the future.

Co-authorship network of co-authors of David M. Scollard

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Scollard. A scholar is included among the top collaborators of David M. Scollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Scollard. David M. Scollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Target product profiles: leprosy diagnostics 2024 ·Bulletin of the World Health Organization ·Petra Kukkaro, Sundeep Chaitanya Vedithi, David J. Blok, Wim H. van Brakel, Annemieke Geluk, Aparna Srikantam, David M. Scollard, Linda B. Adams, (unknown), (unknown), (unknown), Israel Cruz, (unknown), Daniel Argaw Dagne, Kingsley Asiedu, (unknown)	6
2	An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++ 2018 ·BMC Infectious Diseases ·Liesbeth Mieras, (unknown), Wim H. van Brakel, Emmanuelle Cambau, Paul Saunderson, William C. Smith, Cita Rosita Sigit Prakoeswa, (unknown), David M. Scollard, (unknown), J Grosset, H K Kar, Shinzo Izumi, Laura Gillini, Marcos Virmond, Marieke G. G. Sturkenboom	31
3	qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients 2017 ·PLoS neglected tropical diseases ·Sérgio Araújo, Luíz Ricardo Goulart, Richard W. Truman, Isabela Maria Bernardes Goulart, Varalakshmi Vissa, Wei Li, Masanori Matsuoka, Philip Noël Suffys, (unknown), Patrícia Sammarco Rosa, David M. Scollard, Diana L. Williams	14
4	Mechanisms of nerve injury in leprosy 2014 ·Clinics in Dermatology ·David M. Scollard, Richard W. Truman, Gigi J. Ebenezer	52
5	Leprosy of Lucio and Latapí with extremity livedoid vascular changes 2013 ·International Journal of Dermatology ·Arianne Shadi Kourosh, Jack B. Cohen, David M. Scollard, Sharon Nations	2
6	Evaluation of Multi-Drug Therapy for Leprosy in the United States Using Daily Rifampin 2011 ·Southern Medical Journal ·Mara M. Dacso, Robert R. Jacobson, David M. Scollard, Barbara M. Stryjewska, (unknown)	14
7	Hansen's disease (leprosy) complicated by secondary mycobacterial infection 2010 ·Journal of the American Academy of Dermatology ·David M. Scollard, Barbara M. Stryjewska, (unknown), Thomas P. Gillis, (unknown)	7
8	Emergence of an effective adaptive cell mediated immune response toMycobacterium lepraeis not impaired in reactive oxygen intermediate-deficient mice 2007 ·FEMS Immunology & Medical Microbiology ·Deanna A. Hagge, (unknown), (unknown), Marilyn A. Dietrich, Michael T. Kearney, David M. Scollard, James L. Krahenbuhl, Linda B. Adams	6
9	Electron Microscopic Appearance of Lepromatous Foodpads of Nude Mice1 2003 ·PubMed ·C. K. Job, (unknown), David M. Scollard, Richard W. Truman	5
10	Lepromatous phlebitis of the external jugular vein 2003 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Kristi J. Robson, M. Patricia Joyce, David Fivenson, David M. Scollard	7
11	A New Model for Studying the Effects ofMycobacterium lepraeon Schwann Cell and Neuron Interactions 2002 ·The Journal of Infectious Diseases ·Deanna A. Hagge, (unknown), David M. Scollard, (unknown), Diana L. Williams	28
12	The Study ofMycobacterium lepraeInfection in Interferon‐γ Gene–Disrupted Mice as a Model to Explore the Immunopathologic Spectrum of Leprosy 2002 ·The Journal of Infectious Diseases ·Linda B. Adams, David M. Scollard, (unknown), Andrea M. Cooper, Anthony A. Frank, Ian M. Orme, James L. Krahenbuhl	35
13	Association of Mycobacterium Leprae with Human Endothelial Cells In Vitro 2000 ·Laboratory Investigation ·David M. Scollard	11
14	Endothelial cells and the pathogenesis of lepromatous neuritis:insights from the armadillo model 2000 ·Microbes and Infection ·David M. Scollard	32
15	Polymerase Chain Reaction Assay for the Detection and Identification ofMycobacterium lepraein Patients in the United States 1998 ·American Journal of Clinical Pathology ·David M. Scollard, Thomas P. Gillis, Diana L. Williams	42
16	Reactivity of a Population of Armadillo Lymphocytes with an Antibody to Human γ,δ T-Cells 1997 ·Clinical Immunology and Immunopathology ·(unknown), David M. Scollard, Marilyn A. Dietrich	4
17	Exacerbation of Acute and Chronic Murine Tuberculosis by Administration of a Tumor Necrosis Factor Receptor-Expressing Adenovirus 1995 ·The Journal of Infectious Diseases ·Linda B. Adams, Carol M. Mason, Jay K. Kolls, David M. Scollard, James L. Krahenbuhl, Steve Nelson	73
18	Localization of a novel pathway for the liberation of GABA in the human CNS 1994 ·Brain Research Bulletin ·Mel C. Jackson, David M. Scollard, Randall J. Mack, James F. Lenney	30
19	Immune complexes and antibody levels in blisters over human leprosy skin lesions with or without erythema nodosum leprosum 1992 ·Clinical Immunology and Immunopathology ·David M. Scollard, (unknown), Luc Kestens, Guido Vanham, James T. Douglas, John C. Moad	12
20	Release of soluble interleukin-2 receptors (Tac peptide) in vivo during human immune responses to tuberculin 1988 ·Clinical Immunology and Immunopathology ·David M. Scollard, David K. Wagner, David L. Nelson	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact